NCT06688409

Brief Summary

This study aims to assess whether validated and non-validated blood pressure measuring devices sold on the online market are accurate in regards to the mean awake BP from ambulatory blood pressure monitoring.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
19mo left

Started Feb 2024

Longer than P75 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Feb 2024Nov 2027

Study Start

First participant enrolled

February 12, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 14, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

3.8 years

First QC Date

November 12, 2024

Last Update Submit

February 12, 2025

Conditions

Keywords

hypertensionblood pressure measurementblood pressureblood pressure device validation

Outcome Measures

Primary Outcomes (1)

  • Mean difference in systolic BP

    Mean difference in systolic BP between the home BP device and the awake ABPM

    At enrollment (time 0)

Secondary Outcomes (3)

  • Mean difference in diastolic BP

    At enrollment (time 0)

  • Mean difference in systolic BP from validated device

    At enrollment (time 0)

  • Mean difference in diastolic BP from validated device

    At enrollment (time 0)

Study Arms (4)

Validate home BP device

ACTIVE COMPARATOR

BP measured with a validated home BP device

Diagnostic Test: awake ABPM

Non-validated home BP device #1

ACTIVE COMPARATOR

BP measured with the first non-validated home BP device

Diagnostic Test: awake ABPM

Non-validated home BP device #2

ACTIVE COMPARATOR

BP measured with the second non-validated home BP device

Diagnostic Test: awake ABPM

Non-validated home BP device #3

ACTIVE COMPARATOR

BP measured with the third non-validated home BP device

Diagnostic Test: awake ABPM

Interventions

awake ABPMDIAGNOSTIC_TEST

Comparison of a BP measured with the home BP devices and the average awake ABPM performed immediately after

Non-validated home BP device #1Non-validated home BP device #2Non-validated home BP device #3Validate home BP device

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged \> 18 years scheduled to undergo an ABPM

You may not qualify if:

  • Upper arm size outside of cuff range of selected devices (\<22 cm or \>42 cm)
  • Night shift workers
  • Permanent atrial fibrillation
  • Known severe aortic stenosis
  • Contraindication to measure BP on the non-dominant arm
  • Ongoing pregnancy
  • Inability or unwillingness to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Sacré-Coeur de Montréal

Montreal, Quebec, H4J 1C5, Canada

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Remi Goupil, MD MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 12, 2024

First Posted

November 14, 2024

Study Start

February 12, 2024

Primary Completion (Estimated)

November 30, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

February 14, 2025

Record last verified: 2025-02

Locations